Biopharmacy, diagnosis, cell therapy and regenerative medicine are the current issues included in medical biotechnology in Iran. In the last decade, 12 biotechnology products have been registered in Iran. Furthermore, it is expected that more than 15 products of recombinant proteins and monoclonal antibodies are approved within a few years. Fabricating a number of recombinant proteins in bio-pharmaceutics is now finished or given certification. Private companies manufactured a wide variety of recombinant proteins in molecular biology and molecular diagnostic kits. These biotechnology companies extensively export their products to Europe, South America, India, Egypt and Pakistan.
OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals with the support of 50,000+ editorial board members as editorial team and aimed to disseminate the scholarly knowledge to the scientific society.
Last date updated on April, 2024